Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AASLD, advocacy, affinity, anniversary, annum, ASCO, AstraZeneca, behalf, BeneFIX, binding, biomarker, BMS, bond, bore, borrow, borrowed, Bristol, buying, cancelled, climate, closer, cohort, collateral, complimentary, concept, concomitant, configuration, content, context, contractor, conventional, corroborated, Deerfield, default, digit, downgraded, drawn, driven, drop, eleven, entirety, exemplify, exit, explain, faulty, FIFO, flat, follicular, genotype, helper, hesitant, hierarchy, highlighted, Ig, inexpensive, influential, infusion, input, instrument, intensify, intermediate, irrevocable, issuable, IU, lender, licensee, licensor, light, load, loan, log, lot, MAA, manifestation, military, mouse, MTD, mTOR, multiply, narrowly, navigate, obsolescence, oral, orderly, output, parking, partnership, Paymentfor, payroll, penalty, PhRMA, PLC, problematic, procedure, promulgated, rapamycin, reacquired, reacquisition, repay, rescheduled, retroactive, rolling, saving, settlement, solid, sound, speaker, static, strength, stringent, Symposium, Systagenix, tandem, TFH, threshold, title, Torisel, twenty, Unadjusted, unaware, unconfirmed, undeveloped, unexpected, unobservable, unrestricted, untimely, UW, vial, warranted, weekly, ZG
Removed:
abnormally, added, adding, adhere, advancement, aim, andin, assume, autoantibody, beta, breadth, bring, calculating, capacity, capture, Children, clear, collaborated, conservation, consume, cultured, Currentin, decided, decreasing, defray, deliver, designating, detrimental, diversified, diversify, duration, elevated, Eli, endpoint, enroll, equally, essential, evenly, examined, exceeded, excessive, exclusivity, explore, exploring, falling, fare, Finally, flexibility, floor, forego, forgoing, formula, funded, goal, harmful, hospital, improve, inappropriate, inception, infiltration, inhibiting, interrupt, Jude, kidney, knowledge, leaving, leukemia, lie, lieu, Lilly, lymphocytic, magnitude, malfunction, malignant, myeloma, nearby, negotiation, noncurrent, NovoRapid, occupied, omrix, origin, overactivity, owner, par, possessed, predating, prolong, proteinuria, relying, renting, request, resembling, SAB, select, separation, serum, software, spend, spending, split, St, stabilization, starving, strong, subjective, subordinated, succeeding, survive, syndrome, targeting, Tennessee, theory, transformed, transition, underwritten, unencumbered, unlimited, validate, vigorously, worse
Filing tables
Filing exhibits
- 10-K Annual report
- 10.43 Release and License Agreement
- 23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification Pursuant to Section 302 of the Sarbanes-oxley Act
- 31.2 Certification Pursuant to Section 302 of the Sarbanes-oxley Act
- 32.1 Certification Pursuant to Section 906 of the Sarbanes-oxley Act
Related press release
ZGEN similar filings
Filing view
External links
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-125917) and Form S-8 (Nos. 333-82012 and 333-141326) of ZymoGenetics, Inc. of our report dated March 5, 2009, relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Seattle, Washington
March 5, 2009